NCT06178536 is a NA clinical trial of Bone Consumption in Surgical Technique, sponsored by Christian Makary.

Who is sponsoring NCT06178536?

NCT06178536 is sponsored by Christian Makary.

What drugs are being tested in NCT06178536?

Interventions in NCT06178536: Bone Consumption, Bone expansion.

What condition does NCT06178536 study?

NCT06178536 studies Surgical Technique, Implant Surface.

Is NCT06178536 still recruiting?

NCT06178536 is currently completed. Last updated 21 December 2023.

Last reviewed 2023-12-21 · How we verify

NCT06178536

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical and Radiographic Assessment of a Novel Wedge Shape Implant Placed in Edentulous Narrow Ridges

Completed NA Last updated 21 December 2023

What this trial tests

NA trial testing Bone Consumption in Surgical Technique in 18 participants. Completed in 1 December 2023.

Timeline

3 June 2021

Primary endpoint
1 December 2023

1 December 2023

Quick facts

Lead sponsor	Christian Makary
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	18
Start date	3 June 2021
Primary completion	1 December 2023
Estimated completion	1 December 2023
Sites	1 location across Lebanon

Drugs / interventions tested

Bone Consumption
Bone expansion

Conditions studied

Surgical Technique — all drugs for Surgical Technique →
Implant Surface — all drugs for Implant Surface →

Sponsor

Christian Makary

Who can join

Adults 35 to 62, any sex, with Surgical Technique or Implant Surface. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim is to clinically and radiographically assess a novel wedge implant placed in narrow ridges. * 60 wedge implants (Rex Implants, Columbus, OH, USA) will be placed using Piezosurgery® following either a bone consumption (n=30) or bone expansion technique (n=30). Each group (bone consumption and bone expansion) will be divided into 2 surface treatments: machined transcortical portion (n=15) and roughened transcortical portion (n=15). * Record the time needed to place each implant. * ISQ will be evaluated at Day 0, 3 weeks, 6 weeks, 3 months, 4 months, and 6 months after implant placement. * Periapical radiographs will be performed at implant placement, loading. and 1, 3, and 5 years after loading to assess marginal bone stability. * Buccal bone height and lingual and buccal bone thickness will be recorded post-intervention, at the time of functional loading, and at 12, 36, and 60 months after loading with CBCT. * Digital impressions will be taken post-operatively, at loading and at 12 months after loading to monitor gingival profile.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06178536 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Christian Makary
Last refreshed: 21 December 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06178536.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing